Clinical trial of Bifidobacterium breve Yakult for short bowel syndrome

Clinical trial of Bifidobacterium breve Yakult for short bowel syndrome - Clinical trial of Bifidobacterium breve Yakult for short bowel syndrome

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000001885

Enrollment

Registered

2009-06-01

Start date

2009-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

short bowel syndrome

Interventions

Bidobacterium breve Yakult 3g/day, oral or enteral tube administration

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: short bowel syndrome with growth reterdation

Exclusion criteria

Exclusion criteria: short bowel syndrome with good clinical status

Design outcomes

Primary

Measure	Time frame
about body hight, body wight, head circumference, calorie of erental nutrition and calorie of parental nutrition, every 4 weeks, endpoint is 52 weeks.	—

Countries

Japan

Contacts

Public ContactHideyuki Sasaki

Tohoku University Hospital

h-sasaki@ped-surg.med.tohoku.ac.jp022-717-7237

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026